Key result
New-onset atrial fibrillation was independently associated with a increased risk of in-hospital death compared to no atrial fibrillation in patients with infective endocarditis.
Why the study?
Few large-sample studies have evaluated the incidence, risk factors, and prognostic value of new-onset AF in patients with infective endocarditis.
Does new-onset atrial fibrillation increase the risk of mortality in patients with infective endocarditis?
Observational (n=1,063)
No
Does new-onset atrial fibrillation increase the risk of mortality in patients with infective endocarditis?
New-onset atrial fibrillation in patients with infective endocarditis is an independent predictor of short-term and in-hospital mortality.
Answers are grounded in this paper and cite their sources.
New-onset AF warrants close monitoring in IE; leaves open whether rhythm interventions alter outcomes.
BACKGROUND: Few studies with a large sample size have been performed to evaluate the incidence, risk factors and prognostic value of new-onset atrial fibrillation (AF) in patients with infective endocarditis (IE). METHODS AND RESULTS: A total of 1,063 IE patients were included and 83 developed new AF. Compared with no-AF, the incidence of in-hospital death (6.0% vs. 22.9%, P<0.001) was higher in patients with new-onset AF. New-onset AF was independently associated with increased risk of in-hospital (adjusted odds ratio [OR]=3.92, P=0.001) and 1-year death (adjusted hazard ratio=2.91, P=0.001), while prior AF was not an independent factor. Kaplan-Meier curve analysis demonstrated new-onset AF mainly affected short-term death (180 days). Age (OR=1.04, P<0.001), rheumatic heart disease (OR=1.88, P=0.022), NYHA Class III or IV (OR=2.09, P=0.003), and left atrial diameter (LAD; OR=1.05, P=0.006) were independent risk factors for development of new AF. CONCLUSIONS: New-onset AF, not prior AF, was a prognostic factor in IE patients, which was mainly associated with increased risk of short-term death. Patients with concomitant rheumatic heart disease, poor cardiac function, and larger LAD had higher risk of developing new AF.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2019) conducted an observational in Infective endocarditis (n=1,063). New-onset atrial fibrillation vs. No atrial fibrillation was evaluated on In-hospital all-cause death (adjusted OR 3.92, 95% CI 1.70-9.04, p=0.001). New-onset atrial fibrillation was independently associated with a increased risk of in-hospital death compared to no atrial fibrillation in patients with infective endocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: